Jonathan Yong
Stock Analyst at UBS
(2.57)
# 1,953
Out of 4,959 analysts
102
Total ratings
58.93%
Success rate
10.08%
Average return
Main Sectors:
Stocks Rated by Jonathan Yong
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| EHTH eHealth | Maintains: Neutral | $7 → $5 | $3.84 | +30.21% | 6 | Aug 7, 2025 | |
| CLOV Clover Health Investments | Maintains: Neutral | $4.5 → $3 | $2.73 | +9.89% | 4 | Aug 6, 2025 | |
| OSCR Oscar Health | Downgrades: Sell | $15 → $11 | $16.80 | -34.52% | 8 | Jul 15, 2025 | |
| PINC Premier | Maintains: Neutral | $33 → $25 | $25.14 | -0.56% | 2 | Aug 24, 2023 | |
| WBA Walgreens Boots Alliance | Maintains: Neutral | $33 → $30 | $12.07 | +148.55% | 5 | Aug 24, 2023 | |
| EHAB Enhabit | Maintains: Neutral | $15 → $12 | $8.19 | +46.52% | 3 | Aug 11, 2023 | |
| GDRX GoodRx Holdings | Maintains: Neutral | $7 → $8 | $4.56 | +75.44% | 4 | Aug 10, 2023 | |
| CCRN Cross Country Healthcare | Maintains: Neutral | $27 → $26 | $14.15 | +83.75% | 2 | Aug 8, 2023 | |
| HIMS Hims & Hers Health | Reiterates: Outperform | $14 | $44.57 | -68.59% | 3 | Aug 8, 2023 | |
| HSIC Henry Schein | Reiterates: Outperform | $96 | $69.60 | +37.93% | 3 | Aug 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $29 → $32 | $13.42 | +138.45% | 3 | Aug 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $115 → $105 | $20.75 | +406.02% | 4 | Aug 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $76 → $80 | $122.83 | -34.87% | 3 | Aug 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $247 → $231 | $278.18 | -16.96% | 6 | Aug 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | $27 | $7.68 | +251.56% | 5 | Jul 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $90 → $100 | $148.10 | -32.48% | 2 | Jun 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $430 → $450 | $689.45 | -34.73% | 3 | May 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $15 → $12 | $4.06 | +195.57% | 3 | May 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $80 → $70 | $7.15 | +879.02% | 2 | May 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $14 → $17 | $15.78 | +7.77% | 2 | Apr 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $347 → $350 | $174.44 | +100.64% | 3 | Apr 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $93 → $95 | $22.44 | +323.35% | 1 | Apr 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underperform | $7 → $8.5 | $5.62 | +51.25% | 2 | Apr 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $41 | $21.97 | +86.62% | 2 | Mar 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $20 → $17 | $5.05 | +236.63% | 2 | Mar 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $3.3 → $8.5 | $2.76 | +207.97% | 2 | Feb 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $85 | $81.50 | +4.29% | 1 | Feb 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $143 → $146 | $180.23 | -18.99% | 1 | Jan 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $104 → $106 | $29.41 | +260.42% | 3 | Dec 19, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $129 → $157 | $185.58 | -15.40% | 1 | Nov 25, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $329 → $368 | $304.35 | +20.91% | 2 | Nov 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $548 → $635 | $299.51 | +112.01% | 2 | Nov 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $113 → $117 | $71.30 | +64.10% | 2 | Aug 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $31 → $30 | $17.01 | +76.37% | 1 | May 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $267 → $298 | $404.97 | -26.41% | 1 | Oct 25, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $88 → $95 | $179.50 | -47.08% | 2 | Oct 22, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $462 → $495 | $307.42 | +61.02% | 1 | Oct 15, 2021 |
eHealth
Aug 7, 2025
Maintains: Neutral
Price Target: $7 → $5
Current: $3.84
Upside: +30.21%
Clover Health Investments
Aug 6, 2025
Maintains: Neutral
Price Target: $4.5 → $3
Current: $2.73
Upside: +9.89%
Oscar Health
Jul 15, 2025
Downgrades: Sell
Price Target: $15 → $11
Current: $16.80
Upside: -34.52%
Premier
Aug 24, 2023
Maintains: Neutral
Price Target: $33 → $25
Current: $25.14
Upside: -0.56%
Walgreens Boots Alliance
Aug 24, 2023
Maintains: Neutral
Price Target: $33 → $30
Current: $12.07
Upside: +148.55%
Enhabit
Aug 11, 2023
Maintains: Neutral
Price Target: $15 → $12
Current: $8.19
Upside: +46.52%
GoodRx Holdings
Aug 10, 2023
Maintains: Neutral
Price Target: $7 → $8
Current: $4.56
Upside: +75.44%
Cross Country Healthcare
Aug 8, 2023
Maintains: Neutral
Price Target: $27 → $26
Current: $14.15
Upside: +83.75%
Hims & Hers Health
Aug 8, 2023
Reiterates: Outperform
Price Target: $14
Current: $44.57
Upside: -68.59%
Henry Schein
Aug 8, 2023
Reiterates: Outperform
Price Target: $96
Current: $69.60
Upside: +37.93%
Aug 7, 2023
Maintains: Neutral
Price Target: $29 → $32
Current: $13.42
Upside: +138.45%
Aug 4, 2023
Maintains: Outperform
Price Target: $115 → $105
Current: $20.75
Upside: +406.02%
Aug 4, 2023
Maintains: Outperform
Price Target: $76 → $80
Current: $122.83
Upside: -34.87%
Aug 2, 2023
Maintains: Outperform
Price Target: $247 → $231
Current: $278.18
Upside: -16.96%
Jul 26, 2023
Reiterates: Neutral
Price Target: $27
Current: $7.68
Upside: +251.56%
Jun 12, 2023
Maintains: Neutral
Price Target: $90 → $100
Current: $148.10
Upside: -32.48%
May 12, 2023
Maintains: Outperform
Price Target: $430 → $450
Current: $689.45
Upside: -34.73%
May 5, 2023
Maintains: Neutral
Price Target: $15 → $12
Current: $4.06
Upside: +195.57%
May 4, 2023
Maintains: Neutral
Price Target: $80 → $70
Current: $7.15
Upside: +879.02%
Apr 28, 2023
Maintains: Neutral
Price Target: $14 → $17
Current: $15.78
Upside: +7.77%
Apr 28, 2023
Maintains: Outperform
Price Target: $347 → $350
Current: $174.44
Upside: +100.64%
Apr 28, 2023
Maintains: Outperform
Price Target: $93 → $95
Current: $22.44
Upside: +323.35%
Apr 4, 2023
Maintains: Underperform
Price Target: $7 → $8.5
Current: $5.62
Upside: +51.25%
Mar 7, 2023
Reiterates: Outperform
Price Target: $41
Current: $21.97
Upside: +86.62%
Mar 7, 2023
Maintains: Neutral
Price Target: $20 → $17
Current: $5.05
Upside: +236.63%
Feb 17, 2023
Maintains: Neutral
Price Target: $3.3 → $8.5
Current: $2.76
Upside: +207.97%
Feb 16, 2023
Reiterates: Outperform
Price Target: $85
Current: $81.50
Upside: +4.29%
Jan 25, 2023
Maintains: Neutral
Price Target: $143 → $146
Current: $180.23
Upside: -18.99%
Dec 19, 2022
Maintains: Outperform
Price Target: $104 → $106
Current: $29.41
Upside: +260.42%
Nov 25, 2022
Maintains: Outperform
Price Target: $129 → $157
Current: $185.58
Upside: -15.40%
Nov 7, 2022
Maintains: Outperform
Price Target: $329 → $368
Current: $304.35
Upside: +20.91%
Nov 3, 2022
Maintains: Outperform
Price Target: $548 → $635
Current: $299.51
Upside: +112.01%
Aug 8, 2022
Maintains: Outperform
Price Target: $113 → $117
Current: $71.30
Upside: +64.10%
May 3, 2022
Maintains: Outperform
Price Target: $31 → $30
Current: $17.01
Upside: +76.37%
Oct 25, 2021
Maintains: Outperform
Price Target: $267 → $298
Current: $404.97
Upside: -26.41%
Oct 22, 2021
Maintains: Outperform
Price Target: $88 → $95
Current: $179.50
Upside: -47.08%
Oct 15, 2021
Maintains: Outperform
Price Target: $462 → $495
Current: $307.42
Upside: +61.02%